Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia

Mycoses

Volumn 58, Issue 6, 2015, Pages 343-349

  Aslan, Muge ^a   Oz, Yasemin ^b   Aksit, Filiz ^b   Akay, Olga M ^b  

^a Yozgat State Hospital   (Turkey)

^b OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Diagnosis; Invasive aspergillosis; Polymerase chain reaction

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEBRILE NEUTROPENIA; FEMALE; GALACTOMANNAN ANTIGEN TEST; HUMAN; INVASIVE ASPERGILLOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT; ASPERGILLUS; CHEMISTRY; GENETICS; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PROCEDURES; SEROLOGY;

ASPERGILLUS;

FUNGAL DNA; GALACTOMANNAN; MANNAN;

ADULT; ASPERGILLUS; DNA, FUNGAL; FEBRILE NEUTROPENIA; FEMALE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; YOUNG ADULT;

EID: 84929515002     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12322     Document Type: Article

References (27)

1. Nosari AM, Caira M, Pioltelli ML et al. Hemae-Chart registry of invasive fungal infections in hematological patients: improved outcome in recent years in mould infections. Clin Microbiol Infect 2013; 19: 757-62.
2. De Pauw B, Walsh TJ, Donnelly JP, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
3. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762-9.
4. Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med 2012; 125: 14-24.
5. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011; 66: 5-14.
6. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research, 4th ed. Oxford, UK: Blackwell Science Ltd, 2002.
7. Kawazu M, Kanda Y, Nannya Y et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1 → 3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733-41.
8. Perfect RJ. Fungal diagnosis: how do we do it and can we do better. Curr Med Res Opin 2013; 29: 3-11.
9. White PL, Perry MD, Moody A, Follett SA, Morgan G, Barnes RA. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J Clin Microbiol 2011; 49: 2169-74.
10. Torelli R, Sanguinetti M, Moody Pagano L et al. Diagnosis of invasive aspergillosis by a commercial real-time PCR for Aspergillus DNA in bronchoalveolar lavage fluid samples from high risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 2011; 49: 4273-8.
11. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 89-96.
12. Springer J, Schlossnagel H, Heinz W et al. A novel extraction method combining plasma with whole-blood fraction shows excellent sensitivity and reproducibility for patients at high risk for invasive aspergillosis. J Clin Microbiol 2012; 50: 2585-891.
13. Millon L, Piarroux R, Deconinck E et al. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J Clin Microbiol 2005; 43: 5097-101.
14. Maertens J, Theunissen K, Lodewyck M, Lagrou K, Van Eldere J. Advances in the serological diagnosis of invasive Aspergillus infections in patients with hematological disorders. Mycoses 2007; 50: 2-17.
15. Badiee P, Kordbacheh P, Alborzi A, Ramzi M, Shakiba E. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection 2008; 36: 580-4.
16. Suarez F, Lortholary O, Buland S et al. Detection of circulating Aspergillus fumigates DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. J Clin Microbiol 2008; 46: 3772-7.
17. Challier S, Boyer S, Abachin E, Berche P. Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2004; 42: 844-6.
18. Rogers TR, Morton CO, Springer J et al. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies. Br J Haematol 2013; 161: 517-24.
19. Cuenca-Estrella M, Meije Y, Diaz-Pedroche C et al. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J Clin Microbiol 2009; 47: 379-84.
20. McCulloch E, Ramage G, Rajendran R et al. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. J Clin Pathol 2012; 65: 83-86.
21. Luong ML, Clancy CJ, Vadnerkar A et al. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin Infect Dis 2011; 52: 1218-26.
22. Hadrich I, Mary C, Makni F et al. Comparison of PCR ELISA and real-time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies. Med Mycol 2011; 49: 489-94.
23. Reinwald M, Spiess B, Heinz WJ et al. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples. Eur J Haematol 2012; 89: 120-7.
24. Bergeron A, Porcher R, Sulahian Ade Bazelaire C et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood 2012; 119: 1831-7.
25. Beirao F, Araujo R. State of the art diagnostic of mold diseases: a practical guide for clinicians. Eur J Clin Microbiol Infect Dis 2012; 12: 1722-7.
26. Danylo A, Courttemanche C, Pelletier R, Boudreault A. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples. Med Mycol 2014; 52: 577-83. doi: 10.1093/mmy/myu25.
27. Meije Y, Aguado JM, Cuenca-Estrella M. Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implications. Bone Marrow Transplant 2011; 46: 1016-17.